The different immunoregulatory functions of mesenchymal stem cells in patients with low-risk or high-risk myelodysplastic syndromes
about
Immune Mechanisms in Myelodysplastic SyndromeMesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?Beyond the Niche: Myelodysplastic Syndrome Topobiology in the Laboratory and in the ClinicThe roles of mesenchymal stem cells in tumor inflammatory microenvironmentMesenchymal stem cells in pathogenesis of myelodysplastic syndromesInfluence of TNF and IL6 gene polymorphisms on the severity of cytopenias in Argentine patients with myelodysplastic syndromes.MicroRNA-23a mediates post-transcriptional regulation of CXCL12 in bone marrow stromal cellsDown-regulation of Dicer1 promotes cellular senescence and decreases the differentiation and stem cell-supporting capacities of mesenchymal stromal cells in patients with myelodysplastic syndrome.Mesenchymal stromal cells from patients with myelodyplastic syndrome display distinct functional alterations that are modulated by lenalidomide.De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes.Mesenchymal stem cells in immune-mediated bone marrow failure syndromes.The inflammatory microenvironment in MDS.Mesenchymal stromal cells in myeloid malignancies.Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells.
P2860
Q26744500-303851C3-A0F4-4921-A210-A8D36ACF8949Q26746104-D4AB113E-2296-4660-82DF-002ADC0EC59DQ26752778-999ED590-850C-453B-A523-56D0EFE3FF62Q26823759-1D0A7F2A-C5BF-41D6-A94F-091F190CD501Q27011323-F353C3BB-F9E3-4546-AD20-5A6355F14415Q33442617-E1A71C5B-3CA4-4842-B003-4BEA36351EB5Q35105333-52A229EF-6250-42D0-8803-7A9A8D997D7FQ36715982-B5836CB0-92D8-48B8-9828-21811885E8A4Q37273157-E4040C0E-B530-4A6F-BACC-4C55744728DAQ37584726-1B70921B-1A26-495F-8101-2AB917BB1BC8Q38175397-59DAE062-118B-4446-9646-05D6657F8967Q38348119-9C96DC45-4DD7-4B0E-8E3F-B7BF1E32D17EQ39090002-98F6B4C8-5E54-44E4-8E6A-1A603C10B424Q44998014-A9D55917-C5C6-4C51-8DA9-1FD931624F33
P2860
The different immunoregulatory functions of mesenchymal stem cells in patients with low-risk or high-risk myelodysplastic syndromes
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The different immunoregulatory ...... risk myelodysplastic syndromes
@ast
The different immunoregulatory ...... risk myelodysplastic syndromes
@en
The different immunoregulatory ...... risk myelodysplastic syndromes
@nl
type
label
The different immunoregulatory ...... risk myelodysplastic syndromes
@ast
The different immunoregulatory ...... risk myelodysplastic syndromes
@en
The different immunoregulatory ...... risk myelodysplastic syndromes
@nl
prefLabel
The different immunoregulatory ...... risk myelodysplastic syndromes
@ast
The different immunoregulatory ...... risk myelodysplastic syndromes
@en
The different immunoregulatory ...... risk myelodysplastic syndromes
@nl
P2093
P2860
P1433
P1476
The different immunoregulatory ...... risk myelodysplastic syndromes
@en
P2093
Weiming Li
Zhenling Wang
Zhigang Zhao
P2860
P304
P356
10.1371/JOURNAL.PONE.0045675
P407
P577
2012-09-21T00:00:00Z